Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
71
SOLV Quote, Financials, Valuation and Earnings
Last price:
$73.87
Seasonality move
:
43.9%
Day range:
$71.98 - $73.75
52-week range:
$49.64 - $85.92
Dividend yield:
0%
P/E ratio:
33.81x
P/S ratio:
1.53x
P/B ratio:
3.87x
Volume:
530.9K
Avg. volume:
799.7K
1-year change:
45.94%
Market cap:
$12.6B
Revenue:
$8.3B
EPS (TTM):
$2.16
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.3B | $8.2B | $8.1B | $8.2B | $8.3B | |
| Revenue Growth (YoY) | -- | 12.22% | -0.5% | 0.82% | 0.7% | |
| Cost of Revenues | $3B | $3.2B | $3.4B | $3.5B | $3.7B | |
| Gross Profit | $4.3B | $4.9B | $4.7B | $4.7B | $4.6B | |
| Gross Profit Margin | 59.26% | 60.25% | 57.75% | 57.25% | 55.65% | |
| R&D Expenses | $719M | $766M | $767M | $758M | $775M | |
| Selling, General & Admin | $2.2B | $2.3B | $2.2B | $2.2B | $2.8B | |
| Other Inc / (Exp) | $10M | $3M | -$1M | -$25M | -$64M | |
| Operating Expenses | $2.9B | $3B | $3B | $3B | $3.6B | |
| Operating Income | $1.4B | $1.9B | $1.7B | $1.7B | $1B | |
| Net Interest Expenses | -- | -- | -- | -- | $367M | |
| EBT. Incl. Unusual Items | $1.4B | $1.9B | $1.7B | $1.7B | $605M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $302M | $422M | $349M | $321M | $127M | |
| Net Income to Company | $1.1B | $1.5B | $1.3B | $1.3B | $479M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $1.5B | $1.3B | $1.3B | $479M | |
| Basic EPS (Cont. Ops) | $6.59 | $8.45 | $7.78 | $7.79 | $2.77 | |
| Diluted EPS (Cont. Ops) | $6.59 | $8.45 | $7.78 | $7.79 | $2.76 | |
| Weighted Average Basic Share | $172.7M | $172.7M | $172.7M | $172.7M | $173.2M | |
| Weighted Average Diluted Share | $172.7M | $172.7M | $172.7M | $172.7M | $173.7M | |
| EBITDA | $2B | $2.5B | $2.3B | $2.2B | $1.5B | |
| EBIT | $1.4B | $1.9B | $1.7B | $1.7B | $972M | |
| Revenue (Reported) | $7.3B | $8.2B | $8.1B | $8.2B | $8.3B | |
| Operating Income (Reported) | $1.4B | $1.9B | $1.7B | $1.7B | $1B | |
| Operating Income (Adjusted) | $1.4B | $1.9B | $1.7B | $1.7B | $972M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $2B | $2B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | 0.25% | 2.68% | |
| Cost of Revenues | -- | -- | $874M | $844M | $956M | |
| Gross Profit | -- | -- | $1.1B | $1.2B | $1.1B | |
| Gross Profit Margin | -- | -- | 56.54% | 58.14% | 53.82% | |
| R&D Expenses | -- | -- | $195M | $195M | $193M | |
| Selling, General & Admin | -- | -- | $577M | $596M | $769M | |
| Other Inc / (Exp) | -- | -- | -$2M | -$13M | -$11M | |
| Operating Expenses | -- | -- | $772M | $791M | $962M | |
| Operating Income | -- | -- | $365M | $381M | $152M | |
| Net Interest Expenses | -- | -- | -- | $39M | $104M | |
| EBT. Incl. Unusual Items | -- | -- | $363M | $329M | $38M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $70M | $92M | -$99M | |
| Net Income to Company | -- | -- | $293M | $237M | $137M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $293M | $237M | $137M | |
| Basic EPS (Cont. Ops) | -- | -- | $1.70 | $1.37 | $0.79 | |
| Diluted EPS (Cont. Ops) | -- | -- | $1.70 | $1.37 | $0.78 | |
| Weighted Average Basic Share | -- | -- | $172.7M | $172.7M | $173.7M | |
| Weighted Average Diluted Share | -- | -- | $172.7M | $172.7M | $174.8M | |
| EBITDA | -- | -- | $508M | $507M | $271M | |
| EBIT | -- | -- | $363M | $368M | $142M | |
| Revenue (Reported) | -- | -- | $2B | $2B | $2.1B | |
| Operating Income (Reported) | -- | -- | $365M | $381M | $152M | |
| Operating Income (Adjusted) | -- | -- | $363M | $368M | $142M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $8.2B | $8.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $3.5B | $3.8B | |
| Gross Profit | -- | -- | -- | $4.7B | $4.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $758M | $773M | |
| Selling, General & Admin | -- | -- | -- | $2.3B | $3B | |
| Other Inc / (Exp) | -- | -- | -$4M | -$36M | -$62M | |
| Operating Expenses | -- | -- | -- | $3B | $3.7B | |
| Operating Income | -- | -- | -- | $1.7B | $807M | |
| Net Interest Expenses | -- | -- | -- | $39M | $432M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $1.6B | $314M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $343M | -$64M | |
| Net Income to Company | -- | -- | -- | $1.3B | $379M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $1.3B | $379M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $7.47 | $2.17 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $7.47 | $2.16 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $2.2B | $1.3B | |
| EBIT | -- | -- | -- | $1.7B | $746M | |
| Revenue (Reported) | -- | -- | -- | $8.2B | $8.3B | |
| Operating Income (Reported) | -- | -- | -- | $1.7B | $807M | |
| Operating Income (Adjusted) | -- | -- | -- | $1.7B | $746M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $2B | $2B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $874M | $844M | $956M | |
| Gross Profit | -- | -- | $1.1B | $1.2B | $1.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $195M | $195M | $193M | |
| Selling, General & Admin | -- | -- | $577M | $596M | $769M | |
| Other Inc / (Exp) | -- | -- | -$2M | -$13M | -$11M | |
| Operating Expenses | -- | -- | $772M | $791M | $962M | |
| Operating Income | -- | -- | $365M | $381M | $152M | |
| Net Interest Expenses | -- | -- | -- | $39M | $104M | |
| EBT. Incl. Unusual Items | -- | -- | $363M | $329M | $38M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $70M | $92M | -$99M | |
| Net Income to Company | -- | -- | $293M | $237M | $137M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $293M | $237M | $137M | |
| Basic EPS (Cont. Ops) | -- | -- | $1.70 | $1.37 | $0.79 | |
| Diluted EPS (Cont. Ops) | -- | -- | $1.70 | $1.37 | $0.78 | |
| Weighted Average Basic Share | -- | -- | $172.7M | $172.7M | $173.7M | |
| Weighted Average Diluted Share | -- | -- | $172.7M | $172.7M | $174.8M | |
| EBITDA | -- | -- | $508M | $507M | $271M | |
| EBIT | -- | -- | $363M | $368M | $142M | |
| Revenue (Reported) | -- | -- | $2B | $2B | $2.1B | |
| Operating Income (Reported) | -- | -- | $365M | $381M | $152M | |
| Operating Income (Adjusted) | -- | -- | $363M | $368M | $142M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $91M | $61M | $194M | $762M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $1.2B | $1.2B | $1.3B | $1B | |
| Inventory | -- | $813M | $873M | $857M | $965M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $108M | $126M | $155M | $293M | |
| Total Current Assets | -- | $2.2B | $2.2B | $2.5B | $3.2B | |
| Property Plant And Equipment | -- | $1.3B | $1.3B | $1.5B | $1.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $6.7B | $6.4B | $6.5B | $6.4B | |
| Other Intangibles | -- | $3.7B | $3.3B | $2.9B | $2.5B | |
| Other Long-Term Assets | -- | $253M | $358M | $530M | $665M | |
| Total Assets | -- | $14.1B | $13.6B | $13.9B | $14.5B | |
| Accounts Payable | -- | $320M | $348M | $477M | $618M | |
| Accrued Expenses | -- | $189M | $168M | $206M | $260M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $200M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $187M | $171M | $156M | $378M | |
| Total Current Liabilities | -- | $1.4B | $1.3B | $1.7B | $2.7B | |
| Long-Term Debt | -- | -- | -- | $8.3B | $7.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $2B | $1.9B | $2.3B | $11.5B | |
| Common Stock | -- | -- | -- | -- | $2M | |
| Other Common Equity Adj | -- | -- | -- | -$337M | -$1.1B | |
| Common Equity | -- | $12.1B | $11.7B | $11.7B | $3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $12.1B | $11.7B | $11.7B | $3B | |
| Total Liabilities and Equity | -- | $14.1B | $13.6B | $13.9B | $14.5B | |
| Cash and Short Terms | -- | $91M | $61M | $194M | $762M | |
| Total Debt | -- | -- | -- | -- | $8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $996M | $534M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $1.2B | $926M | |
| Inventory | -- | -- | -- | $901M | $866M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $242M | $249M | |
| Total Current Assets | -- | -- | -- | $3.4B | $3.1B | |
| Property Plant And Equipment | -- | -- | -- | $1.5B | $1.2B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $6.5B | $5B | |
| Other Intangibles | -- | -- | -- | $2.8B | $2.4B | |
| Other Long-Term Assets | -- | -- | -- | $583M | $2.9B | |
| Total Assets | -- | -- | -- | $14.7B | $14.5B | |
| Accounts Payable | -- | -- | -- | $587M | $604M | |
| Accrued Expenses | -- | -- | -- | $170M | $203M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $100M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | $378M | $388M | |
| Total Current Liabilities | -- | -- | -- | $1.9B | $2.6B | |
| Long-Term Debt | -- | -- | -- | $8.3B | $7.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $10.9B | $11.3B | |
| Common Stock | -- | -- | -- | -- | $2M | |
| Other Common Equity Adj | -- | -- | -- | -- | $9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $3.9B | $3.3B | |
| Total Liabilities and Equity | -- | -- | -- | $14.7B | $14.5B | |
| Cash and Short Terms | -- | -- | -- | $996M | $534M | |
| Total Debt | -- | -- | -- | $8.3B | $7.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $1.5B | $1.3B | $1.3B | $479M | |
| Depreciation & Amoritzation | $599M | $597M | $578M | $561M | $555M | |
| Stock-Based Compensation | $35M | $38M | $37M | $39M | $112M | |
| Change in Accounts Receivable | $41M | -$1M | -$32M | -$129M | $276M | |
| Change in Inventories | $43M | -$136M | -$82M | $23M | -$132M | |
| Cash From Operations | $2B | $2.2B | $1.7B | $1.9B | $1.2B | |
| Capital Expenditures | $271M | $277M | $251M | $290M | $380M | |
| Cash Acquisitions | -- | -- | -- | $60M | -- | |
| Cash From Investing | $228M | -$278M | -$253M | -$230M | -$380M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $8.3B | |
| Long-Term Debt Repaid | -$445M | -- | -- | -- | -$300M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.8B | -$2B | -$1.5B | -$1.6B | -$8.2B | |
| Cash From Financing | -$2.2B | -$2B | -$1.5B | -$1.6B | -$240M | |
| Beginning Cash (CF) | $84M | $124M | $91M | $61M | $194M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $43M | -$36M | -$34M | $133M | $565M | |
| Ending Cash (CF) | $124M | $91M | $61M | $194M | $762M | |
| Levered Free Cash Flow | $1.8B | $1.9B | $1.4B | $1.6B | $805M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $293M | $237M | $137M | |
| Depreciation & Amoritzation | -- | -- | $145M | $139M | $129M | |
| Stock-Based Compensation | -- | -- | $18M | $4M | $49M | |
| Change in Accounts Receivable | -- | -- | $32M | $78M | $11M | |
| Change in Inventories | -- | -- | -$6M | -$52M | -$32M | |
| Cash From Operations | -- | -- | $509M | $442M | $29M | |
| Capital Expenditures | -- | -- | $65M | $102M | $109M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$65M | -$102M | -$114M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $8.3B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$100M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$462M | -$7.8B | -$39M | |
| Cash From Financing | -- | -- | -$462M | $462M | -$139M | |
| Beginning Cash (CF) | -- | -- | $61M | $194M | $762M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $1M | |
| Additions / Reductions | -- | -- | -$18M | $802M | -$224M | |
| Ending Cash (CF) | -- | -- | $43M | $996M | $534M | |
| Levered Free Cash Flow | -- | -- | $444M | $340M | -$80M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $1.3B | $379M | |
| Depreciation & Amoritzation | -- | -- | -- | $555M | $545M | |
| Stock-Based Compensation | -- | -- | $18M | $25M | $157M | |
| Change in Accounts Receivable | -- | -- | -- | -$83M | $209M | |
| Change in Inventories | -- | -- | -- | -$23M | -$112M | |
| Cash From Operations | -- | -- | -- | $1.8B | $772M | |
| Capital Expenditures | -- | -- | $65M | $327M | $387M | |
| Cash Acquisitions | -- | -- | -- | $60M | -- | |
| Cash From Investing | -- | -- | -- | -$267M | -$392M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $8.3B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$8.9B | -$441M | |
| Cash From Financing | -- | -- | -- | -$628M | -$841M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $953M | -$461M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $1.5B | $385M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $293M | $237M | $137M | |
| Depreciation & Amoritzation | -- | -- | $145M | $139M | $129M | |
| Stock-Based Compensation | -- | -- | $18M | $4M | $49M | |
| Change in Accounts Receivable | -- | -- | $32M | $78M | $11M | |
| Change in Inventories | -- | -- | -$6M | -$52M | -$32M | |
| Cash From Operations | -- | -- | $509M | $442M | $29M | |
| Capital Expenditures | -- | -- | $65M | $102M | $109M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$65M | -$102M | -$114M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $8.3B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$100M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$462M | -$7.8B | -$39M | |
| Cash From Financing | -- | -- | -$462M | $462M | -$139M | |
| Beginning Cash (CF) | -- | -- | $61M | $194M | $762M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $1M | |
| Additions / Reductions | -- | -- | -$18M | $802M | -$224M | |
| Ending Cash (CF) | -- | -- | $43M | $996M | $534M | |
| Levered Free Cash Flow | -- | -- | $444M | $340M | -$80M | |
Get SOLV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SOLV
Sector
P/E ratio
33.81x
23.88x
PEG ratio
--
0.00x
P/B ratio
3.87x
1.80x
Price / LTM sales
1.53x
1.65x
Growth Metrics
SOLV
Sector
Revenue growth
2.68%
4.06%
Earnings growth
-43.07%
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
$1.45
-$0.20
Profitability
SOLV
Sector
Profitability FY 2024
$4.6B
$47.5M
Return on invested capital
3.34%
-16.26%
Return on assets
2.6%
-13.27%
Return on equity
11.75%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
7
Balance Sheet
SOLV
Sector
Total cash
$534M
$35.5M
Short term investments
--
$29.7M
Total assets
$14.5B
$106.9M
Long term debt
$7.9B
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
